To the content
2 . 2017

Real world experience of using IFN-free therapy in HCV-infected patients at the Perm Regional Hepatology Center

AbstractThe real world experience of using IFN-sparing combination of paritaprevir/r + ombitasvir + dasabuvir (3D) in 24 patients at the Perm regional hepatology center is presented in this paper. In addition the most interesting clinical cases from this cohort are described and discussed in details.

Keywords:chronic hepatitis C, IFN-free therapy, direct acting antivirals, DAA, paritaprevir, ombitasvir, dasabuvir, real world evidence

Infectious Diseases: News, Opinions, Training. 2017; (2): 102-107.
DOI: 10.24411/2305-3496-2017-00041


All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Aleksandr V. Gorelov
Academician of the Russian Academy of Sciences, MD, Head of Infection Diseases and Epidemiology Department of the Scientific and Educational Institute of Clinical Medicine named after N.A. Semashko ofRussian University of Medicine, Ministry of Health of the Russian Federation, Professor of the Department of Childhood Diseases, Clinical Institute of Children's Health named after N.F. Filatov, Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Deputy Director for Research, Central Research Institute of Epidemiology, Rospotrebnadzor (Moscow, Russian Federation)
Journals of «GEOTAR-Media»